Calpain as a therapeutic target in cancer

References

• Ono Y, Saido TC, Sorimachi H. Calpain research for drug discovery: challenges and potential. Nat Rev Drug Discov. 2016Dec; 15:12. 854–876. https://doi.org/10.1038/nrd.2016.212.
   PubMed Web of Science ®Google Scholar
• Storr SJ, Carragher NO, Frame MC, et al. The calpain system and cancer. Nat Rev Cancer. 2011 May;11(5):364–374. DOI:https://doi.org/10.1038/nrc3050.
   PubMed Web of Science ®Google Scholar
• Chen J, Wu Y, Zhang L, et al. Evidence for calpains in cancer metastasis. J Cell Physiol. 2019 Jun;234(6):8233–8240.
   PubMed Web of Science ®Google Scholar
• LeloupL, Wells A. Calpains as potential anti-cancer targets. Expert Opin Ther Targets. 2011 Mar;15(3):309–323. DOI:https://doi.org/10.1517/14728222.2011.553611.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Akasu R, Miyazaki A. Calpain-Associated Proteolytic Regulation of the Stromal Microenvironment in Cancer. Curr Pharm Des. 2021;27(28):3128–3138.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Miyazaki A. Dysregulation of calpain proteolytic systems underlies degenerative vascular disorders.J Atheroscler Thromb. 2018 [Jan 1];25(1):1–15. DOI:https://doi.org/10.5551/jat.RV17008.
   PubMed Web of Science ®Google Scholar
• Storr SJ, Thompson N, Pu X, et al. Calpain in breast cancer: role in disease progression and treatment response. Pathobiology. 2015 Sep;82(3–4):133–141.
   PubMed Web of Science ®Google Scholar
• Ono Y, Sorimachi H. Calpains — an elaborate proteolytic system. Biochim Biophys Acta. 2012 Jan;1824(1):224–236.
   PubMed Web of Science ®Google Scholar
• Liu Z, Cao J, Gao X, et al. GPS-CCD: a novel computational program for the prediction of calpain cleavage sites. PLoS ONE. 2011;6(4):e19001.
   PubMed Web of Science ®Google Scholar
• Dutt P, Arthur JSC, Croall DE, et al. m -calpain subunits remain associated in the presence of calcium. FEBS Lett. 1998;436(3):367–371.
   PubMed Web of Science ®Google Scholar
• Elce JS, Davies PL, Hegadorn C, et al. The effects of truncations of the small subunit on m-calpain activity and heterodimer formation. Biochem J. 1997;326(1):31–38.
   PubMed Web of Science ®Google Scholar
• Campbell RL, Davies PL. Structure–function relationships in calpains.Biochem J. 2012 [Nov 1];447(3):335–351. DOI:https://doi.org/10.1042/BJ20120921.
   PubMed Web of Science ®Google Scholar
• Strobl S, Fernandez-Catalan C, Braun M, et al. The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc Natl Acad Sci U S A. 2000 [Jan 18];97(2):588–592. DOI:https://doi.org/10.1073/pnas.97.2.588.
   PubMed Web of Science ®Google Scholar
• Moldoveanu T, Hosfield CM, Lim D, et al. A Ca2+ switch aligns the active site of calpain. Cell. 2002;108(5):649–660.
   PubMed Web of Science ®Google Scholar
• Clapham DE. Calcium signaling. Cell. 2007;131(6):1047–1058.
   PubMed Web of Science ®Google Scholar
• Breitwieser GE. Extracellular calcium as an integrator of tissue function. Int J Biochem Cell Biol. 2008;40(8):1467–1480.
   PubMed Web of Science ®Google Scholar
• Hanna RA, Campbell RL, Davies PL. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature. 2008 [Nov 20];456(7220):409–412.
   PubMed Web of Science ®Google Scholar
• Salamino F, Averna M, Tedesco I, et al. Modulation of rat brain calpastatin efficiency by post-translational modifications.FEBS Lett. 1997 [Aug 4];412(3):433–438. DOI:https://doi.org/10.1016/S0014-5793(97)00819-3.
   PubMed Web of Science ®Google Scholar
• Averna M, de Tullio R, Passalacqua M, et al. Changes in intracellular calpastatin localization are mediated by reversible phosphorylation.Biochem J. 2001 [Feb 15];354(1):25–30. DOI:https://doi.org/10.1042/bj3540025.
   PubMed Web of Science ®Google Scholar
• Xu L, Deng X. Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and m-calpains.J Biol Chem. 2006 [Feb 17];281(7):4457–4466. DOI:https://doi.org/10.1074/jbc.M510721200.
   PubMed Web of Science ®Google Scholar
• Shiraha H, Glading A, Chou J, et al. Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol Cell Biol. 2002 Apr;22(8):2716–2727.
   PubMed Web of Science ®Google Scholar
• Bassett EA, Palanichamy K, Pearson M, et al. Calpastatin phosphorylation regulates radiation-induced calpain activity in glioblastoma. Oncotarget. 2018 [Mar 6];9(18):14597–14607. DOI:https://doi.org/10.18632/oncotarget.24523.
   PubMedGoogle Scholar
• Du M, Li X, Li Z, et al. Calpastatin inhibits the activity of phosphorylated μ-calpain in vitro. Food Chem. 2019;274:743–749. Feb 15. DOI:https://doi.org/10.1016/j.foodchem.2018.09.073
   PubMed Web of Science ®Google Scholar
• Moldoveanu T, Gehring K, Green DR. Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains.Nature. 2008 [Nov 20];456(7220):404–408. DOI:https://doi.org/10.1038/nature07353.
   PubMed Web of Science ®Google Scholar
• Moldoveanu T, Campbell RL, Cuerrier D, et al. Crystal structures of calpain–E64 and –leupeptin inhibitor complexes reveal mobile loops gating the active site.J Mol Biol. 2004 [2004 Nov 5];343(5):1313–1326. DOI:https://doi.org/10.1016/j.jmb.2004.09.016.
   PubMed Web of Science ®Google Scholar
• Todd B, Moore D, Deivanayagam CCS, et al. A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor. J Mol Biol. 2003 [2003 Apr 18];328(1):131–146. DOI:https://doi.org/10.1016/S0022-2836(03)00274-2.
   PubMed Web of Science ®Google Scholar
• Croall DE, Moffett K, Hatch H. Casein zymography of calpains using a 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid-imidazole buffer.Anal Biochem. 2002 [May 1];304(1):129–132. DOI:https://doi.org/10.1006/abio.2001.5606.
   PubMed Web of Science ®Google Scholar
• Kelly JC, Cuerrier D, Graham LA, et al. Profiling of calpain activity with a series of FRET-based substrates. Biochim Biophys Acta. 2009 Oct;1794(10):1505–1509.
   PubMed Web of Science ®Google Scholar
• McCartney CE, MacLeod JA, Greer PA, et al. An easy-to-use FRET protein substrate to detect calpain cleavage in vitro and in vivo. Biochim Biophys Acta Mol Cell Res. 2018 Feb;1865(2):221–230.
   PubMed Web of Science ®Google Scholar
• Doucet A, Kleifeld O, Kizhakkedathu JN, et al. Identification of proteolytic products and natural protein N-termini by terminal amine isotopic labeling of substrates (TAILS). Methods Mol Biol. 2011;753:273–287.
   PubMedGoogle Scholar
• Potter DA, Tirnauer JS, Janssen R, et al. Calpain regulates actin remodeling during cell spreading. J Cell Biol. 1998 [May 4];141(3):129–132. DOI:https://doi.org/10.1083/jcb.141.3.647.
   Web of Science ®Google Scholar
• Schoenwaelder SM, Yuan Y, Cooray P, et al. Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin alphaIIbbeta3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots.J Biol Chem. 1997 [Jan 17];272(3):1694–1702. DOI:https://doi.org/10.1074/jbc.272.3.1694.
   PubMed Web of Science ®Google Scholar
• Chen H, Libertini SJ, Wang Y, et al. ERK regulates calpain 2-induced androgen receptor proteolysis in CWR22 relapsed prostate tumor cell lines.J Biol Chem. 2010 [Jan 22];285(4):2368–2374. DOI:https://doi.org/10.1074/jbc.M109.049379.
   PubMed Web of Science ®Google Scholar
• Tan Y, Dourdin N, Wu C, et al. Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis.J Biol Chem. 2006 [Jun 9];281(23):16016–16024. DOI:https://doi.org/10.1074/jbc.M601299200.
   PubMed Web of Science ®Google Scholar
• Tan Y, Wu C, De Veyra T, et al. 2006; Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J Biol Chem. Jun 30. 281:26. 17689–17698. https://doi.org/10.1074/jbc.M601978200.
   PubMed Web of Science ®Google Scholar
• Pelley RP, Chinnakannu K, Murthy S, et al. Calmodulin-androgen receptor (AR) interaction: calcium-dependent, calpain-mediated breakdown of AR in LNCaP prostate cancer cells. Cancer Res. 2006 [Dec 15];66(24):1862–1869. DOI:https://doi.org/10.1158/0008-5472.CAN-06-2918.
   Web of Science ®Google Scholar
• Yoo BH, Wu X, Li Y, et al. Oncogenic ras-induced down-regulation of autophagy mediator Beclin-1 is required for malignant transformation of intestinal epithelial cells. J Biol Chem. 2010 [Feb 19];285(8):5438–5449. DOI:https://doi.org/10.1074/jbc.M109.046789.
   PubMed Web of Science ®Google Scholar
• Chua BT, Guo K, Li P. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases.J Biol Chem. 2000 [Feb 18];275(7):5131–5135. DOI:https://doi.org/10.1074/jbc.275.7.5131.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis.J Cell Biol. 2000 [Aug 21];150(4):887–894. DOI:https://doi.org/10.1083/jcb.150.4.887.
   PubMed Web of Science ®Google Scholar
• Patzke H, Tsai L-H. Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29.J Biol Chem. 2002 [Mar 8];277(10):8054–8060. DOI:https://doi.org/10.1074/jbc.M109645200.
   PubMed Web of Science ®Google Scholar
• Huang C, Tandon NN, Greco NJ, et al. Proteolysis of platelet cortactin by calpain.J Biol Chem. 1997 [Aug 1];272(31):19248–19252. DOI:https://doi.org/10.1074/jbc.272.31.19248.
   PubMed Web of Science ®Google Scholar
• Wang XD, Rosales JL, Magliocco A, et al. Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain.Oncogene. 2003 [Feb 6];22(5):769–774. DOI:https://doi.org/10.1038/sj.onc.1206166.
   PubMed Web of Science ®Google Scholar
• Yao X, Thibodeau A, Forte JG. Ezrin-calpain I interactions in gastric parietal cells. Am J Physiol. 1993 Jul;265(1):C36–46.
   PubMed Web of Science ®Google Scholar
• Kubbutat MH, Vousden KH. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol. 1997 Jan;17(1):8054–8058.
   Web of Science ®Google Scholar
• Tomita T, Huibregtse JM, Matouschek A. A masked initiation region in retinoblastoma protein regulates its proteasomal degradation.Nat Commun. 2020 [Apr 24];11(1):2019. DOI:https://doi.org/10.1038/s41467-020-16003-3.
   PubMed Web of Science ®Google Scholar
• Tonnetti L, Netzel-Arnett S, Darnell GA, et al. SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival. Cancer Res. 2008 [Jul 15];68(14):460–468. DOI:https://doi.org/10.1158/0008-5472.CAN-07-5850.
   Web of Science ®Google Scholar
• Pardo-Pastor C, Rubio-Moscardo F, Vogel-Gonzalez M, et al. Piezo2 channel regulates RhoA and actin cytoskeleton to promote cell mechanobiological responses. Proc Natl Acad Sci U S A. 2018 [Feb 20];115(8):1925–1930. DOI:https://doi.org/10.1073/pnas.1718177115.
   PubMed Web of Science ®Google Scholar
• Ackermann A, Brieger A. The role of nonerythroid spectrin αII in cancer. J Oncol. 2019;2019:7079604.
   PubMed Web of Science ®Google Scholar
• Kwak H-I, Kang H, Dave JM, et al. Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation. Angiogenesis. 2012 Jun;15(2):287–303. DOI:https://doi.org/10.1007/s10456-012-9262-4.
   PubMed Web of Science ®Google Scholar
• Hossain MI, Roulston CL, Kamaruddin MA, et al. A truncated fragment of Src protein kinase generated by calpain-mediated cleavage is a mediator of neuronal death in excitotoxicity. J Biol Chem. 2013 [Apr 5];288(14):9696–9709. DOI:https://doi.org/10.1074/jbc.M112.419713.
   PubMed Web of Science ®Google Scholar
• Mahaman YAR, Huang F, Kessete Afewerky H, et al. Involvement of calpain in the neuropathogenesis of Alzheimer’s disease. Med Res Rev. 2019 Mar;39(2):608–630.
   PubMed Web of Science ®Google Scholar
• Baudry M. Calpain-1 and Calpain-2 in the brain: dr. Jekill and Mr Hyde? Curr Neuropharmacol. 2019;17(9):823–829. DOI:https://doi.org/10.2174/1570159X17666190228112451.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hersheson J, Lopez D, et al. Defects in the CAPN1 gene result in alterations in cerebellar development and cerebellar ataxia in mice and humans. Cell Rep. 2016 [Jun 28];16(1):79–91. DOI:https://doi.org/10.1016/j.celrep.2016.05.044.
   PubMed Web of Science ®Google Scholar
• Azam M, Andrabi SS, Sahr KE, et al. Disruption of the mouse mu-calpain gene reveals an essential role in platelet function. Mol Cell Biol. 2001 Mar;21(6):2213–2220.
   PubMed Web of Science ®Google Scholar
• Richard I, Broux O, Allamand V, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 1995 [Apr 7];81(1):27–40. DOI:https://doi.org/10.1016/0092-8674(95)90368-2.
   PubMed Web of Science ®Google Scholar
• Ono Y, Ojima K, Shinkai-Ouchi F, et al. An eccentric calpain, CAPN3/p94/calpain-3. Biochimie. 2016 Mar;122:169–187.
   PubMed Web of Science ®Google Scholar
• Mahajan VB, Skeie JM, Bassuk AG, et al. Calpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degeneration. PLoS Genet. 2012;8(10):e1003001. DOI:https://doi.org/10.1371/journal.pgen.1003001.
   PubMed Web of Science ®Google Scholar
• Tang PH, Chemudupati T, Wert KJ, et al. Phenotypic variance in Calpain-5 retinal degeneration. Am J Ophthalmol Case Rep. 2020;18:100627.
   PubMedGoogle Scholar
• Kottyan LC, Davis BP, Sherrill JD, et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet. 2014 Aug;46(8):895–900. DOI:https://doi.org/10.1038/ng.3033.
   PubMed Web of Science ®Google Scholar
• Braun C, Engel M, Seifert M, et al. Expression of calpain I messenger RNA in human renal cell carcinoma: correlation with lymph node metastasis and histological type. Int J Cancer. 1999 [Feb 19];84(1):6–9. DOI:https://doi.org/10.1002/(SICI)1097-0215(19990219)84:1<6::AID-IJC2>3.0.CO;2-T.
   PubMed Web of Science ®Google Scholar
• Tang S, Yin Q, Liu F, et al. Calpain small subunit 1 protein in the prognosis of cancer survivors and its clinicopathological correlation. Biomed Res Int. 2019;2019:8053706.
   PubMed Web of Science ®Google Scholar
• Zhao C, Yuan G, Jiang Y, et al. Capn4 contributes to tumor invasion and metastasis in gastric cancer via activation of the Wnt/beta-catenin/MMP9 signalling pathways. Exp Cell Res. 2020 [Oct 15];395(2):112220. DOI:https://doi.org/10.1016/j.yexcr.2020.112220.
   PubMed Web of Science ®Google Scholar
• Xu C, Yu X, Zhu Y, et al. Overexpression of calpain1 predicts poor outcome in patients with colorectal cancer and promotes tumor cell progression associated with downregulation of FLNA. Oncol Rep. 2019 Jun;41(6):3424–3434. DOI:https://doi.org/10.3892/or.2019.7121.
   PubMed Web of Science ®Google Scholar
• Huang C, Miller RT, Freter CE. Signaling regulation and role of filamin A cleavage in Ca2+-stimulated migration of androgen receptor-deficient prostate cancer cells.Oncotarget. 2017 [Jan 17];8(3):3840–3853. DOI:https://doi.org/10.18632/oncotarget.9472.
   PubMedGoogle Scholar
• Gao X, Mao Y-H, Xiao C, et al. Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-kappaB/DNMT1 signaling pathway. Prostate. 2018 Jun;78(9):682–690. DOI:https://doi.org/10.1002/pros.23512.
   PubMed Web of Science ®Google Scholar
• Yu LM, Zhu YS, Xu CZ, et al. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients. Clin Transl Oncol. 2019 Jul;21(7):682–690.
   Web of Science ®Google Scholar
• Yoshida M, Miyasaka Y, Ohuchida K, et al. Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model. Cancer Sci. 2016 Oct;107(10):1443–1452. DOI:https://doi.org/10.1111/cas.13024.
   PubMed Web of Science ®Google Scholar
• Storr SJ, Safuan S, Woolston CM, et al. Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer. J Cell Mol Med. 2012 Oct;16(10):2422–2428. DOI:https://doi.org/10.1111/j.1582-4934.2012.01559.x.
   PubMed Web of Science ®Google Scholar
• Storr SJ, Woolston CM, Barros FF, et al. Calpain-1 expression is associated with relapse-free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy. Int J Cancer. 2011 [Oct 1];129(7):1773–1780. DOI:https://doi.org/10.1002/ijc.25832.
   PubMed Web of Science ®Google Scholar
• Storr SJ, Lee KW, Woolston CM, et al. Calpain system protein expression in basal-like and triple-negative invasive breast cancer. Ann Oncol. 2012 Sep;23(9):2289–2296. DOI:https://doi.org/10.1093/annonc/mds176.
   PubMed Web of Science ®Google Scholar
• Pu X, Storr SJ, Ahmad NS, et al. Calpain-1 is associated with adverse relapse free survival in breast cancer: a confirmatory study. Histopathology. 2016 Jun;68(7):1021–1029. DOI:https://doi.org/10.1111/his.12896.
   PubMed Web of Science ®Google Scholar
• Davis J, Martin SG, Patel PM, et al. Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer. BMC Cancer. 2014 [Dec 23];14(1):995. DOI:https://doi.org/10.1186/1471-2407-14-995.
   PubMed Web of Science ®Google Scholar
• Storr SJ, Zhang S, Perren T, et al. The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy. Oncotarget. 2016 [Jul 26];7(30):47927–47937. DOI:https://doi.org/10.18632/oncotarget.10066.
   PubMedGoogle Scholar
• Storr SJ, Pu X, Davis J, et al. Expression of the calpain system is associated with poor clinical outcome in gastro-oesophageal adenocarcinomas. J Gastroenterol. 2013 Nov;48(11):1213–1221. DOI:https://doi.org/10.1007/s00535-012-0743-4.
   PubMed Web of Science ®Google Scholar
• Storr SJ, Zaitoun AM, Arora A, et al. Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla. BMC Cancer. 2012 [2012 Nov 9];12(1):511. DOI:https://doi.org/10.1186/1471-2407-12-511.
   PubMed Web of Science ®Google Scholar
• Reichrath J, Welter C, Mitschele T, et al. Different expression patterns of calpain isozymes 1 and 2 (CAPN1 and 2) in squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) of human skin. J Pathol. 2003;199(4):509–516. DOI:https://doi.org/10.1002/path.1308.
   PubMed Web of Science ®Google Scholar
• Cai L, Li Q, Li W, et al. Calpain suppresses cell growth and invasion of glioblastoma multiforme by producing the cleavage of filamin A. Int J Clin Oncol. 2020 Jun;25(6):1055–1066. DOI:https://doi.org/10.1007/s10147-020-01636-7.
   PubMed Web of Science ®Google Scholar
• Mair J, Lindahl B, Hammarsten O, et al. How is cardiac troponin released from injured myocardium? European Heart Journal: Acute Cardiovascular Care. 2018;7(6):553–560. DOI:https://doi.org/10.1177/2048872617748553.
   PubMed Web of Science ®Google Scholar
• Kositprapa C, Zhang B, Berger S, et al. Calpain-mediated proteolytic cleavage of troponin I induced by hypoxia or metabolic inhibition in cultured neonatal cardiomyocytes.Mol Cell Biochem. 2000 [2000 Nov 1];214(1):47–55. DOI:https://doi.org/10.1023/A:1007160702275.
   PubMed Web of Science ®Google Scholar
• Vanderklish PW, Bahr BA. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int J Exp Pathol. 2000 Oct;81(5):323–339.
   PubMed Web of Science ®Google Scholar
• Wang Y, Brazdzionis J, Dong F, et al. P13BP, a calpain-2-mediated breakdown product of PTPN13, is a novel blood biomarker for Traumatic Brain Injury. J Neurotrauma. 2021 [Sep 9];38(22):3077–3085. DOI:https://doi.org/10.1089/neu.2021.0229.
   PubMed Web of Science ®Google Scholar
• Zheng D, Su Z, Zhang Y, et al. Calpain-2 promotes MKP-1 expression protecting cardiomyocytes in both in vitro and in vivo mouse models of doxorubicin-induced cardiotoxicity. Arch Toxicol. 2019 Apr;93(4):1051–1065. DOI:https://doi.org/10.1007/s00204-019-02405-w.
   PubMed Web of Science ®Google Scholar
• Boeckel GR, Ehrlich BE. NCS-1 is a regulator of calcium signaling in health and disease. Biochim Biophys Acta Mol Cell Res. 2018 Nov;1865(11):1660–1667.
   PubMed Web of Science ®Google Scholar
• Cetinkaya-Fisgin A, Luan X, Reed N, et al. Cisplatin induced neurotoxicity is mediated by Sarm1 and calpain activation.Sci Rep. 2020 [Dec 14];10(1):21889. DOI:https://doi.org/10.1038/s41598-020-78896-w.
   PubMed Web of Science ®Google Scholar
• Wang MS, Davis AA, Culver DG, et al. Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain. 2003 Mar;127(3):671–679.
   Web of Science ®Google Scholar
• Hoskin V, Szeto A, Ghaffari A, et al. Ezrin regulates focal adhesion and invadopodia dynamics by altering calpain activity to promote breast cancer cell invasion.Mol Biol Cell. 2015 [Oct 1];26(19):3464–3479. DOI:https://doi.org/10.1091/mbc.E14-12-1584.
   PubMed Web of Science ®Google Scholar
• Sundaramoorthy P, Sim JJ, Jang Y-S, et al. Modulation of intracellular calcium levels by calcium lactate affects colon cancer cell motility through calcium-dependent calpain. PLoS One. 2015;10(1):e0116984. DOI:https://doi.org/10.1371/journal.pone.0116984.
   PubMed Web of Science ®Google Scholar
• Lee J, Rosales JL, Byun H-G, et al. L-methadone causes leukemic cell apoptosis via an OPRM1-triggered increase in IP3R-mediated ER Ca(2+) release and decrease in Ca(2+) efflux, elevating [Ca(2+)](i).Sci Rep. 2021 [Jan 13];11(1):1009. DOI:https://doi.org/10.1038/s41598-020-80520-w.
   PubMed Web of Science ®Google Scholar
• Shi M, Zhang T, Sun L, et al. Calpain, Atg5 and Bak play important roles in the crosstalk between apoptosis and autophagy induced by influx of extracellular calcium. Apoptosis. 2013 Apr;18(4):435–451. DOI:https://doi.org/10.1007/s10495-012-0786-2.
   PubMed Web of Science ®Google Scholar
• Escalante AM, McGrath RT, Karolak MR, et al. Preventing the autophagic survival response by inhibition of calpain enhances the cytotoxic activity of bortezomib in vitro and in vivo. Cancer Chemother Pharmacol. 2013 Jun;71(6):1567–1576.
   PubMed Web of Science ®Google Scholar
• Duquette PM, Lamarche-Vane N. The calcium-activated protease calpain regulates netrin-1 receptor deleted in colorectal cancer-induced axon outgrowth in cortical neurons. J Neurochem. 2020 Feb;152(3):1051–1065.
   Web of Science ®Google Scholar
• Michel JJC, Scott JD. AKAP mediated signal transduction. Annu Rev Pharmacol Toxicol. 2002;42(1):235–257.
   PubMed Web of Science ®Google Scholar
• Gafni J, Cong X, Chen SF, et al. Calpain-1 cleaves and activates caspase-7.J Biol Chem. 2009 [Sep 11];284(37):25441–25449. DOI:https://doi.org/10.1074/jbc.M109.038174.
   PubMed Web of Science ®Google Scholar
• Gao G, Dou QP. N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death.J Cell Biochem. 2021 [Sep 18];80(1):53–72. DOI:https://doi.org/10.1002/1097-4644(20010101)80:1<53::AID-JCB60>3.0.CO;2-E.
   Google Scholar
• Yeo J-K, Cha S-D, Cho C-H, et al. Se-methylselenocysteine induces apoptosis through caspase activation and Bax cleavage mediated by calpain in SKOV-3 ovarian cancer cells. Cancer Lett. 2002 [Aug 8];182(1):83–92. DOI:https://doi.org/10.1016/S0304-3835(02)00075-7.
   PubMed Web of Science ®Google Scholar
• Mandic A, Viktorsson K, Strandberg L, et al. Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol Cell Biol. 2002 May;22(9):3003–3013. DOI:https://doi.org/10.1128/MCB.22.9.3003-3013.2002.
   PubMed Web of Science ®Google Scholar
• Andree M, Seeger JM, Schull S, et al. Bid -dependent release of mitochondrial SMAC dampens XIAP -mediated immunity against Shigella. EMBO J. 2014 [Oct 1];33(19):224–236. DOI:https://doi.org/10.15252/embj.201387244.
   Web of Science ®Google Scholar
• Zhuang Q, Shen J, Chen Z, et al. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4. Cancer Biomark. 2018;23(4):515–525. DOI:https://doi.org/10.3233/CBM-181645.
   PubMed Web of Science ®Google Scholar
• Hirai S, Kawasaki H, Yaniv M, et al. Degradation of transcription factors, c-Jun and c-Fos, by calpain.FEBS Lett. 1991 [Aug 5];287(1–2):57–61. DOI:https://doi.org/10.1016/0014-5793(91)80015-U.
   PubMed Web of Science ®Google Scholar
• Pozo K, Bibb JA. The emerging role of Cdk5 in cancer. Trends Cancer. 2016 Oct;2(10):606–618.
   PubMed Web of Science ®Google Scholar
• Norberg E, Gogvadze V, Ott M, et al. An increase in intracellular Ca2+ is required for the activation of mitochondrial calpain to release AIF during cell death. Cell Death Differ. 2008 Dec;15(12):1857–1864. DOI:https://doi.org/10.1038/cdd.2008.123.
   PubMed Web of Science ®Google Scholar
• Gonen H, Shkedy D, Barnoy S, et al. On the involvement of calpains in the degradation of the tumor suppressor protein p53.FEBS Lett. 1997 [Apr 7];406(1–2):17–22. DOI:https://doi.org/10.1016/S0014-5793(97)00225-1.
   PubMed Web of Science ®Google Scholar
• Woo MG, Xue K, Liu J, et al. Calpain-mediated processing of p53-associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking.J Biol Chem. 2012 [Feb 3];287(6):3963–3975. DOI:https://doi.org/10.1074/jbc.M111.314765.
   PubMed Web of Science ®Google Scholar
• Conacci-Sorrell M, Ngouenet C, Anderson S, et al. Stress-induced cleavage of Myc promotes cancer cell survival.Genes Dev. 2014 [Apr 1];28(7):689–707. DOI:https://doi.org/10.1101/gad.231894.113.
   PubMed Web of Science ®Google Scholar
• Conacci-Sorrell M, Ngouenet C, Eisenman RN. Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation.Cell. 2010 [Aug 6];142(3):480–493. DOI:https://doi.org/10.1016/j.cell.2010.06.037.
   PubMed Web of Science ®Google Scholar
• Grieve S, Gao Y, Hall C, et al. 2016; Calpain genetic disruption and HSP90 inhibition combine to attenuate mammary tumorigenesis. Mol Cell Biol. Aug 1. 36:15. 2078–2088. https://doi.org/10.1128/MCB.01062-15.
   PubMed Web of Science ®Google Scholar
• Ho W-C, Pikor L, Gao Y, et al. Calpain 2 regulates Akt-FoxO-p27(Kip1) protein signaling pathway in mammary carcinoma.J Biol Chem. 2012 [May 4];287(19):15458–15465. DOI:https://doi.org/10.1074/jbc.M112.349308.
   PubMed Web of Science ®Google Scholar
• Bertoli C, Copetti T, Lam EWF, et al. Calpain small-1 modulates Akt/FoxO3A signaling and apoptosis through PP2A.Oncogene. 2009 [2009 Feb 1];28(5):721–733. DOI:https://doi.org/10.1038/onc.2008.425.
   PubMed Web of Science ®Google Scholar
• Xu L, Deng X. Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of mu- and m-calpains.J Biol Chem. 2006 [Nov 17];281(46):15458–15465. DOI:https://doi.org/10.1074/jbc.M607702200.
   Web of Science ®Google Scholar
• Fernandes M, Duplaquet L, Tulasne D. Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase. BMB Rep. 2019 Apr;52(4):239–249.
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Reddy KB, Esteva FJ, et al. Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer.Oncogene. 2010 [Mar 4];29(9):1339–1350. DOI:https://doi.org/10.1038/onc.2009.422.
   PubMed Web of Science ®Google Scholar
• MacLeod JA, Gao Y, Hall C, et al. Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib.Oncotarget. 2018 [Sep 7];9(70):33382–33395. DOI:https://doi.org/10.18632/oncotarget.26078.
   PubMedGoogle Scholar
• Ai M, Qiu S, Lu Y, et al. HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain. Cell Signal. 2013 Sep;25(9):1754–1761.
   PubMed Web of Science ®Google Scholar
• Bernaudo S, Khazai S, Honarparvar E, et al. Epidermal growth factor promotes cyclin G2 degradation via calpain-mediated proteolysis in gynaecological cancer cells. PLoS One. 2017;12(6):e0179906.
   PubMed Web of Science ®Google Scholar
• Libertini SJ, Robinson BS, Dhillon NK, et al. Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype. Cancer Res. 2005 [Dec 1];65(23):10700–10708. DOI:https://doi.org/10.1158/0008-5472.CAN-05-1666.
   PubMed Web of Science ®Google Scholar
• Choi YH, Lee SJ, Nguyen P, et al. Regulation of cyclin D1 by calpain protease. J Biol Chem. 1997 [Nov 7];272(45):28479–28484. DOI:https://doi.org/10.1074/jbc.272.45.28479.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu NM, Wang Y, et al. Endothelial cell calpain as a critical modulator of angiogenesis. Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1326–1335.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Taketomi Y, Saito Y, et al. Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells. Circ Res. 2015 [Mar 27];116(7):1170–1181. DOI:https://doi.org/10.1161/CIRCRESAHA.116.305363.
   PubMed Web of Science ®Google Scholar
• Franco SJ, Rodgers MA, Perrin BJ, et al. Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nat Cell Biol. 2004 [2004 Oct 1];6(10):977–983. DOI:https://doi.org/10.1038/ncb1175.
   PubMed Web of Science ®Google Scholar
• Chan KT, Bennin DA, Huttenlocher A. Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK).J Biol Chem. 2010 [Apr 9];285(15):11418–11426. DOI:https://doi.org/10.1074/jbc.M109.090746.
   PubMed Web of Science ®Google Scholar
• Zhuang Q, Luo W, Zhang M, et al. Capn4 contributes to tumor invasion and metastasis in clear cell renal cell carcinoma cells via modulating talin-focal adhesion kinase signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2018 [May 1];50(5):465–472. DOI:https://doi.org/10.1093/abbs/gmy031.
   PubMed Web of Science ®Google Scholar
• Perrin BJ, Amann KJ, Huttenlocher A. Proteolysis of cortactin by calpain regulates membrane protrusion during cell migration. Mol Biol Cell. 2006 Jan;17(1):239–250.
   PubMed Web of Science ®Google Scholar
• Cortesio CL, Chan KT, Perrin BJ, et al. Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion. J Cell Biol. 2008 [Mar 10];180(5):957–971. DOI:https://doi.org/10.1083/jcb.200708048.
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Goll DE, Fox JE. Calpain cleaves RhoA generating a dominant-negative form that inhibits integrin-induced actin filament assembly and cell spreading.J Biol Chem. 2002 [Jul 5];277(27):24435–24441. DOI:https://doi.org/10.1074/jbc.M203457200.
   PubMed Web of Science ®Google Scholar
• Rios-Doria J, Day KC, Kuefer R, et al. The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem. 2003 [Jan 10];278(2):1372–1379. DOI:https://doi.org/10.1074/jbc.M208772200.
   PubMed Web of Science ®Google Scholar
• Rios-Doria J, Kuefer R, Ethier SP, et al. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells.Cancer Res. 2004 [Oct 15];64(20):7237–7240. DOI:https://doi.org/10.1158/0008-5472.CAN-04-1048.
   PubMed Web of Science ®Google Scholar
• Franco S, Perrin B, Huttenlocher A. Isoform specific function of calpain 2 in regulating membrane protrusion.Exp Cell Res. 2004 [Sep 10];299(1):179–187. DOI:https://doi.org/10.1016/j.yexcr.2004.05.021.
   PubMed Web of Science ®Google Scholar
• Serrano K, Devine DV. Vinculin is proteolyzed by calpain during platelet aggregation: 95 kDa cleavage fragment associates with the platelet cytoskeleton. Cell Motil Cytoskeleton. 2004 Aug;58(4):242–252.
   PubMed Web of Science ®Google Scholar
• Chang S-J, Chen Y-C, Yang C-H, et al. Revealing the three dimensional architecture of focal adhesion components to explain Ca(2+)-mediated turnover of focal adhesions. Biochim Biophys Acta Gen Subj. 2017 Mar;1861(3):624–635. DOI:https://doi.org/10.1016/j.bbagen.2017.01.002.
   PubMed Web of Science ®Google Scholar
• J-c W, Chen Y-C, Kuo C-T, et al. Focal adhesion kinase-dependent focal adhesion recruitment of SH2 domains directs SRC into focal adhesions to regulate cell adhesion and migration. Sci Rep. 2015 [2015 Dec 18];5(1):18476. DOI:https://doi.org/10.1038/srep18476.
   PubMed Web of Science ®Google Scholar
• Salimi R, Bandaru S, Devarakonda S, et al. Blocking the cleavage of filamin a by calpain inhibitor decreases tumor cell growth. Anticancer Res. 2018 Apr;38(4):957–971. DOI:https://doi.org/10.21873/anticanres.12447.
   Web of Science ®Google Scholar
• Zheng X, Zhou AX, Rouhi P, et al. Hypoxia-induced and calpain-dependent cleavage of filamin A regulates the hypoxic response. Proc Natl Acad Sci U S A. 2014 [Feb 18];111(7):2560–2565. DOI:https://doi.org/10.1073/pnas.1320815111.
   PubMed Web of Science ®Google Scholar
• McGrath MJ, Binge LC, Sriratana A, et al. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer. Cancer Res. 2013 [Aug 15];73(16):5066–5079. DOI:https://doi.org/10.1158/0008-5472.CAN-12-4520.
   PubMed Web of Science ®Google Scholar
• Libertini SJ, Tepper CG, Rodriguez V, et al. Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen Independence.Cancer Res. 2007 [Oct 1];67(19):9001–9005. DOI:https://doi.org/10.1158/0008-5472.CAN-07-1072.
   PubMed Web of Science ®Google Scholar
• Sivanandam A, Murthy S, Chinnakannu K, et al. Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells. J Cell Physiol. 2011 Jul;226(7):1889–1896. DOI:https://doi.org/10.1002/jcp.22516.
   PubMed Web of Science ®Google Scholar
• Mamoune A, Luo J-H, Lauffenburger DA, et al. Calpain-2 as a target for limiting prostate cancer invasion. Cancer Res. 2003 [Aug 1];63(15):4632–4640.
   PubMed Web of Science ®Google Scholar
• Taylor J, Azimi I, Monteith G, et al. Ca(2+) mediates extracellular vesicle biogenesis through alternate pathways in malignancy. J Extracell Vesicles. 2020;9(1):1734326.
   PubMed Web of Science ®Google Scholar
• Goll DE, Thompson VF, Li H, et al. The calpain system. Physiol Rev. 2003 Jul;83(3):731–801.
   PubMed Web of Science ®Google Scholar
• Taylor J, Patio K, De Rubis G, et al. Membrane to cytosol redistribution of αII-spectrin drives extracellular vesicle biogenesis in malignant breast cells. Proteomics. 2021 Apr 19;21(13–14):e2000091.
   PubMed Web of Science ®Google Scholar
• Larsen AK, Lametsch R, Elce J, et al. Genetic disruption of calpain correlates with loss of membrane blebbing and differential expression of RhoGDI-1, cofilin and tropomyosin. Biochem J. 2008 [May 1];411(3):657–666. DOI:https://doi.org/10.1042/BJ20070522.
   PubMed Web of Science ®Google Scholar
• Redpath GM, Woolger N, Piper AK, et al. Calpain cleavage within dysferlin exon 40a releases a synaptotagmin-like module for membrane repair. Mol Biol Cell. 2014 [Oct 1];25(19):3037–3048. DOI:https://doi.org/10.1091/mbc.e14-04-0947.
   PubMed Web of Science ®Google Scholar
• Tsuchiya K, Hosojima S, Hara H, et al. Gasdermin D mediates the maturation and release of IL-1α downstream of inflammasomes. Cell Rep. 2021 [Mar 23];34(12):108887. DOI:https://doi.org/10.1016/j.celrep.2021.108887.
   PubMed Web of Science ®Google Scholar
• Wiggins KA, Parry AJ, Cassidy LD, et al. IL-1α cleavage by inflammatory caspases of the noncanonical inflammasome controls the senescence-associated secretory phenotype. Aging Cell. 2019 Jun;18(3):e12946. DOI:https://doi.org/10.1111/acel.12946.
   PubMed Web of Science ®Google Scholar
• Shumway SD, Maki M, Miyamoto S. The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain.J Biol Chem. 1999 [Oct 22];274(43):30874–30881. DOI:https://doi.org/10.1074/jbc.274.43.30874.
   PubMed Web of Science ®Google Scholar
• Li C, Yao H, Wang H, et al. Repurposing screen identifies amlodipine as an inducer of PD-L1 degradation and antitumor immunity. Oncogene. 2021 Feb;40(6):1128–1146.
   PubMed Web of Science ®Google Scholar
• Ji J, Su L, Liu Z. Critical role of calpain in inflammation. Biomed Rep. 2016 Dec;5(6):647–652.
   PubMedGoogle Scholar
• Donkor IO. An update on the therapeutic potential of calpain inhibitors: a patent review. Expert Opin Ther Pat. 2020 Sep;30(9):659–675.
   PubMed Web of Science ®Google Scholar
• Fiorino F, Gil-Parrado S, Assfalg-Machleidt I, et al. A new cell-permeable calpain inhibitor. J Pept Sci. 2007 Jan;13(1):70–73.
   PubMed Web of Science ®Google Scholar
• Gil-Parrado S, Assfalg-Machleidt I, Fiorino F, et al. Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin. Biol Chem. 2003 Mar;384(3):395–402. DOI:https://doi.org/10.1515/BC.2003.045.
   PubMed Web of Science ®Google Scholar
• Kalash L, Cresser-Brown J, Habchi J, et al. Structure-based design of allosteric calpain-1 inhibitors populating a novel bioactivity space. Eur J Med Chem. 2018 [Sep 5];157:1264–1275.
   PubMed Web of Science ®Google Scholar
• Low KE, Karunan Partha S, Davies PL, et al. Allosteric inhibitors of calpains: reevaluating inhibition by PD150606 and LSEAL. Biochim Biophys Acta. 2014 Dec;1840(12):3367–3373.
   PubMed Web of Science ®Google Scholar
• Kuchay SM, Chishti AH. Calpain-mediated regulation of platelet signaling pathways. Curr Opin Hematol. 2007 May;14(3):249–254.
   PubMed Web of Science ®Google Scholar
• Piper A-K, Sophocleous RA, Ross SE, et al. Loss of calpains-1 and −2 prevents repair of plasma membrane scrape injuries, but not small pores, and induces a severe muscular dystrophy. Am J Physiol Cell Physiol. 2020 [Jun 1];318(6):C1226–c37. DOI:https://doi.org/10.1152/ajpcell.00408.2019.
   PubMed Web of Science ®Google Scholar
• Takano J, Mihira N, Fujioka R, et al. Vital role of the calpain-calpastatin system for placental-integrity-dependent embryonic survival. Mol Cell Biol. 2011 Oct;31(19):4097–4106.
   PubMed Web of Science ®Google Scholar
• Dutt P, Croall DE, Arthur JS, et al. m-calpain is required for preimplantation embryonic development in mice. BMC Dev Biol. 2006 [Jan 24];6(1):3. DOI:https://doi.org/10.1186/1471-213X-6-3.
   PubMed Web of Science ®Google Scholar
• Lai -L-L, Chen Y-J, Li Y-L, et al. Novel CAPN1 mutations extend the phenotypic heterogeneity in combined spastic paraplegia and ataxia. Ann Clin Transl Neurol. 2020 Oct;7(10):1862–1869. DOI:https://doi.org/10.1002/acn3.51169.
   PubMed Web of Science ®Google Scholar
• Kim A, Kumar KR, Davis RL, et al. Increased diagnostic yield of spastic paraplegia with or without cerebellar ataxia through whole-genome sequencing. Cerebellum. 2019 Aug;18(4):781–790. DOI:https://doi.org/10.1007/s12311-019-01038-0.
   PubMed Web of Science ®Google Scholar
• Sedarous M, Keramaris E, O’Hare M, et al. Calpains mediate p53 activation and neuronal death evoked by DNA damage. J Biol Chem. 2003 [Jul 11];278(28):26031–26038. DOI:https://doi.org/10.1074/jbc.M302833200.
   PubMed Web of Science ®Google Scholar
• Seo J, Jo SA, Hwang S, et al. Trichostatin A epigenetically increases calpastatin expression and inhibits calpain activity and calcium-induced SH-SY5Y neuronal cell toxicity. Febs J. 2013 Dec;280(24):6691–6701. DOI:https://doi.org/10.1111/febs.12572.
   PubMed Web of Science ®Google Scholar
• Winer A, Adams S, Mignatti P. Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes. Mol Cancer Ther. 2018 Jun;17(6):1147–1155.
   PubMed Web of Science ®Google Scholar
• Manasanch EE, Orlowski RZ. Proteasome inhibitors in cancer therapy.Nat Rev Clin Oncol. 2017 [2017 July 1];14(7):417–433. DOI:https://doi.org/10.1038/nrclinonc.2016.206.
   PubMed Web of Science ®Google Scholar
• Tan G-J, Peng Z-K, Lu J-P, et al. Cathepsins mediate tumor metastasis.World J Biol Chem. 2013 [Nov 26];4(4):91–101. DOI:https://doi.org/10.4331/wjbc.v4.i4.91.
   PubMedGoogle Scholar
• Kwaan HC, McMahon B. The role of plasminogen-plasmin system in cancer. Cancer Treat Res. 2009;148:43–66.
   PubMedGoogle Scholar
• Tan CRC, Abdul-Majeed S, Cael B, et al. Clinical pharmacokinetics and pharmacodynamics of bortezomib. Clin Pharmacokinet. 2019 Feb;58(2):157–168.
   PubMed Web of Science ®Google Scholar